Your browser doesn't support javascript.
loading
New polyprenyl phosphate based preparation Fortepren(®) as promising cytokine regulationg antiviral remedy.
Pronin, Alexander V; Narovlyansky, Alexander N; Shulzhenko, Andrey E; Sanin, Alexander V; Sedov, Alexander M.
Afiliación
  • Pronin AV; N. F. Gamaleya Federal Research Center for Epidemiology and Microbiology of the Ministry of Health of Russian Federation, 18, Gamaleya Str., Moscow 123098, Russia. Electronic address: proninalexander@yandex.ru.
  • Narovlyansky AN; N. F. Gamaleya Federal Research Center for Epidemiology and Microbiology of the Ministry of Health of Russian Federation, 18, Gamaleya Str., Moscow 123098, Russia.
  • Shulzhenko AE; National Research Center Institute of Immunology of the Federal Medical Biological Agency of the Russian Federation, 24-2, Kashirskoe Shosse, Moscow 115478, Russia.
  • Sanin AV; N. F. Gamaleya Federal Research Center for Epidemiology and Microbiology of the Ministry of Health of Russian Federation, 18, Gamaleya Str., Moscow 123098, Russia.
  • Sedov AM; N. F. Gamaleya Federal Research Center for Epidemiology and Microbiology of the Ministry of Health of Russian Federation, 18, Gamaleya Str., Moscow 123098, Russia.
Cytokine Growth Factor Rev ; 30: 119-26, 2016 08.
Article en En | MEDLINE | ID: mdl-27235090
Fortepren(®), a product of the phosphorylation of polyprenols from fir needles (with sodium polyprenyl phosphate being the main active ingredient), belongs to the class of antiviral drugs with immunomodulating activity. Fortepren(®) may be used as the drug of choice in the treatment of herpes diseases. It was shown that treatment with Fortepren(®) of patients with a chronic recurrent herpes infection after acute phase termination with acyclovir decreased the recurrence rate, as well as the severity of local symptoms. Fortepren(®) treatment of patients with a high incidence of recurrent herpes infection led to an increase in the interferon-producing ability of leucocytes stimulated with NDV, as well as in the production of key cytokines (IL-1ß, IL-15, MIP-1α, IFN-γ, IL-12 (p40), TNF-α, IFN-α2, IL-12 (p70), IL-6) taking part in the protection against viral infection. Data suggest that the action of the drug is directed, first of all, to the cells responsible for the natural resistance of the organism (macrophages, dendritic cells, etc.). The activation of natural immunity appears to be a leading mechanism of protection from herpesviral infection under the influence of polyprenyl phosphate.
Asunto(s)
Palabras clave

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Antivirales / Organofosfatos / Citocinas / Herpes Simple Límite: Animals / Humans Idioma: En Revista: Cytokine Growth Factor Rev Asunto de la revista: ALERGIA E IMUNOLOGIA / BIOQUIMICA Año: 2016 Tipo del documento: Article Pais de publicación: Reino Unido

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Antivirales / Organofosfatos / Citocinas / Herpes Simple Límite: Animals / Humans Idioma: En Revista: Cytokine Growth Factor Rev Asunto de la revista: ALERGIA E IMUNOLOGIA / BIOQUIMICA Año: 2016 Tipo del documento: Article Pais de publicación: Reino Unido